Evidence map›Paper›PMID 39469649›Full record

ArticleFrontiers in oncology2024

Lung bronchiectasisas a paradigm of the interplay between infection and colonization on plastic modulation of the pre-metastatic niche.

Lucrezia Pisanu, Klodjana Mucaj, Valentina Conio, Francesco Bertuccio, Ilaria Giana, Lorenzo Arlando, Marianna Russo, Simone Montini, Chandra Bortolotto, Angelo Guido Corsico and 1 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Lucrezia Pisanu *Department of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, Italy.
Klodjana Mucaj *Department of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, Italy.
Valentina Conio *Department of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, Italy.
Francesco BertuccioDepartment of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, Italy.
Ilaria GianaDepartment of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, Italy.
Lorenzo ArlandoDepartment of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, Italy.
Marianna RussoDepartment of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, Italy.
Simone MontiniDepartment of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, Italy.
Chandra BortolottoDiagnostic Imaging and Radiotherapy Unit, Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia Medical School, Pavia, Italy.
Angelo Guido CorsicoDepartment of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, Italy.
Giulia Maria StellaDepartment of Internal Medicine and Medical Therapeutics, University of Pavia Medical School, Pavia, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lungs are most often a preferential target organ for malignant spreading and growth. It is well known that chronic parenchymal inflammation and prolonged injuries represents an independent risk factor for cancer onset. Growing evidence supports the implication of lung microbiota in the pathogenesis of lung cancer. However, the full interplay between chronic inflammation, bacterial colonization, pathologic condition as bronchiectasis and malignant growth deserves better clarification. We here aim at presenting and analyzing original data and discussing the state-of-the-art on the knowledge regarding how this complex milieu acts on the plasticity of the lung pre-metastatic niche to point out the rationale for early diagnosis and therapeutic targeting.

Indexed as

bronchiectasiscancerinflammationmicrobiomepre-metastatic niche

Identifiers

PMID39469649
PMCPMC11513253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.